NCT04052568View on ClinicalTrials.gov

Effects of Psilocybin in Anorexia Nervosa

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

January 5, 2022

Study Completion Date

April 20, 2023

Conditions
Anorexia Nervosa
Interventions
DRUG

Psilocybin

Participants will undergo up to four moderate to high dose psilocybin sessions. Dosing at the first session will be 20 mg. For subsequent sessions participants will either remain at their previous dose, or increase by increments of 5 mg up to a maximum of 30 mg.

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04052568 - Effects of Psilocybin in Anorexia Nervosa | Biotech Hunter | Biotech Hunter